Summary: This article discusses the treatment of patients with immunoglobulin light chain amyloidosis.

Summary: Cardiac Amyloidosis Presenting with Pre-Excitation Syndrome, Heart Failure, and Severe Factor X Deficiency as Part of Systemic Amyloid Light-Chain (AL) Amyloidosis - A Fatal Combination.

Summary: Multimodality Imaging in Cardiac Amyloidosis.

Summary: Management of complications of cardiac amyloidosis: 10 questions and answers.

Summary: Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.

Summary: Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis.

Summary: Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance.

Summary: Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.

Summary: The study researched the treatment of transthyretin amyloidosis with NTLA-2001.

Summary: Potential Cardiac Amyloid PET/CT Imaging Targets for Differentiating Immunoglobulin Light Chain From Transthyretin Amyloidosis.

Summary: Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis, Prognosis, and Treatment of Infiltrative Cardiomyopathies.

Summary: Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms.